您当前的位置:
首页 >
文章列表页 >
Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer
更新时间:2023-05-16
    • Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer

    • Genes & Diseases   Vol. 10, Issue 2, (2023)
    • 作者机构:

      1. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400016

      2. Department of Oncology, The Second Affiliated Hospital of Chongqing Medical University,Chongqing,China,400016

      3. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute,Guangdong,Shenzhen,China,518172

      4. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital,Chongqing,China,400030

    • DOI:10.1016/j.gendis.2021.12.019    

      CLC:
    • Published:2023,

      Published Online:1 March 2023,

    扫 描 看 全 文

  • Shuman Li, Xiaoqian He, Yan Wang, et al. Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. [J]. Genes & Diseases 10(2).(2023) DOI: 10.1016/j.gendis.2021.12.019.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine
LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis
Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis

Related Author

Farzad Sadri
Seyede fatemeh Hosseini
Zohreh Rezaei
Mohammad Fereidouni
Zijian Xu
Elizabeth R. Davies
Liudi Yao
Yilu Zhou

Related Institution

Tabas School of Nursing, Birjand University of Medical Sciences, Birjand 971785
Department of Biology, University of Sistan and Baluchestan, Zahedan 981674
Student Research Committee, Birjand University of Medical Sciences, Birjand 971785
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand 971785
Institute for Life Sciences, University of Southampton
0